Alterity Therapeutics (PRNAD) Current Assets (2009 - 2025)

Alterity Therapeutics (PRNAD) has reported Current Assets for 16 consecutive years, with $37.3 million the latest figure, recorded in Q4 2025.

• In Q4 2025, Current Assets rose 446.92% year-over-year to $37.3 million; the TTM figure through Dec 2025 stood at $37.3 million (up 446.92% YoY), while the FY2025 annual figure was $29.4 million, up 134.16% from the prior year.
• Current Assets came in at $37.3 million for Q4 2025 at Alterity Therapeutics, up from $29.4 million in the prior quarter.
• The five-year high for Current Assets was $37.3 million in Q4 2025, with the low at $270487.7 in Q2 2023.
• Average Current Assets over 5 years is $21.0 million, with a median of $23.8 million recorded in 2021.
• Across the five-year window, Current Assets tumbled 99.08% in 2023 and surged 4538.2% in 2024, its largest moves.
• Year by year, Current Assets stood at $32.7 million in 2021, then plunged by 33.24% to $21.8 million in 2022, then slumped by 34.38% to $14.3 million in 2023, then tumbled by 52.35% to $6.8 million in 2024, then jumped by 446.92% to $37.3 million in 2025.
• According to Business Quant data, Current Assets over the past three periods registered $37.3 million, $29.4 million, and $6.8 million for Q4 2025, Q2 2025, and Q4 2024 respectively.